Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.270
-0.030 (-2.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $85.69 million as of April 28, 2025. Its market cap has increased by 15.79% in one year.
Market Cap
85.69M
Enterprise Value
-126.30M
1-Year Change
15.79%
Ranking
Category
Stock Price
1.27
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $85.69M, a decrease of -78.75%. That is a compound annual growth rate of -34.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 85.69M | -29.18% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |